Top Markets
#1 Helium Helium +54.24%
#2 TENDIES TENDIES +42.67%
#3 Pons Pons +31.17%
#4 UnifAI Network UnifAI Network +19.26%
#5 Seeker Seeker +18.62%
#6 Songbird Songbird +12.62%
#7 Lista DAO Lista DAO +11.02%
#8 OSK OSK +10.04%
#9 DAPPOS DAPPOS +9.30%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +8.97%
Coin of the day
Helium Helium
설정
언어
한국어
통화
USD
테마
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
주식 순위 #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
주가
$14.66
마지막 동기화: 2026-08-28
시가총액
$839.37M
변동 (1일)
-2.67%
변동 (1년)
557.32%
국가
US
거래 Climb Bio, Inc. (CLYM)

카테고리

Healthcare
Climb Bio, Inc. (CLYM)의 주가 이력
최고 종가: $15.73 (2026-08-01 기준)

최저 종가: $7.23 (2024-09-01 기준)
Climb Bio, Inc.의 주가 이력 (2024 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 113.43%
2025 31.56%
2024 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH